Edith A Perez

8PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Communication technology and digital media studiesNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 23, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.

Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta

|Mar 07, 2025
Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer.

Saranya Chumsri, Joseph J Larson, Emily Liu

|Jul 10, 2024
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations.

Hesham Elghazaly, Hamdy A Azim, Hope S Rugo

|Jun 02, 2024
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.

Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta

|May 19, 2022
Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review.

Edith A Perez, Chau Dang, Caleb Lee

|Sep 23, 2021
Analysis of Population Differences in Digital Conversations About Cancer Clinical Trials: Advanced Data Mining and Extraction Study.

Edith A Perez, Elizabeth M Jaffee, John Whyte

Pageof 2

Frequent Collaborators

2 joint publications

Matthew J Ellis

2 joint publications

Manuela Rabaglio

2 joint publications

George W Sledge

2 joint publications

Karen A Gelmon